# OnCo record novelty-nobility (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/novelty-nobility/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "novelty-nobility" ;
  schema:name "Novelty Nobility"@en ;
  schema:alternateName "Novelty Nobility, Inc."@en, "Novelty Nobility Inc."@en ;
  schema:description "Novelty Nobility is a Korean antibody company. Its cancer drug NN3201 is an antibody-drug conjugate, an antibody that carries a cell-killing drug, aimed at the c-Kit protein found on some stomach wall tumours (GIST), small cell lung cancer and other cancers."@en ;
  schema:url <https://onco.cc/companies/novelty-nobility/>, <https://www.noveltynobility.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://www.noveltynobility.com/>, <https://www.noveltynobility.com/pipeline/pipeline.php>, <https://clinicaltrials.gov/study/NCT06805825> ;
  schema:addressCountry "KR" ;
  onco:cancers <https://onco.cc/cancers/gist/>, <https://onco.cc/cancers/sclc/>, <https://onco.cc/cancers/adenoid-cystic-carcinoma/>, <https://onco.cc/cancers/uveal-melanoma/>, <https://onco.cc/cancers/neuroendocrine/>, <https://onco.cc/cancers/chromophobe-rcc/>, <https://onco.cc/cancers/rcc/> ;
  onco:sections <https://onco.cc/fronts/adcs/> ;
  onco:technologies <https://onco.cc/technologies/adc/>, <https://onco.cc/technologies/monoclonal-antibody/> ;
  onco:targets <https://onco.cc/targets/kit/> .